Evidence map›Paper›PMID 25483196›Full record

ArticleCell cycle (Georgetown, Tex.)2014

The basic N-terminal domain of TRF2 limits recombination endonuclease action at human telomeres.

Adélaïde Saint-Léger, Melanie Koelblen, Livia Civitelli, Amadou Bah, Nadir Djerbi, Marie-Josèphe Giraud-Panis, Arturo Londoño-Vallejo, Fiorentina Ascenzioni, Eric Gilson

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The evolution of metazoan shelterin.Genes & development · 2021
    Article
  9. The Intra- and Extra-Telomeric Role of TRF2 in the DNA Damage Response.International journal of molecular sciences · 2021
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Adélaïde Saint-Légera Institute for Research on Cancer and Aging, Nice (IRCAN); CNRS UMR7284/INSERM U1081; Faculty of Medicine; Nice, France.
Melanie Koelblen
Livia Civitelli
Amadou Bah
Nadir Djerbi
Marie-Josèphe Giraud-Panis
Arturo Londoño-Vallejo
Fiorentina Ascenzioni
Eric Gilson
Université Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FRDynamique de l'information génétique : bases fondamentales et cancer · FRSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The stability of mammalian telomeres depends upon TRF2, which prevents inappropriate repair and checkpoint activation. By using a plasmid integration assay in yeasts carrying humanized telomeres, we demonstrated that TRF2 possesses the intrinsic property to both stimulate initial homologous recombination events and to prevent their resolution via its basic N-terminal domain. In human cells, we further showed that this TRF2 domain prevents telomere shortening mediated by the resolvase-associated protein SLX4 as well as GEN1 and MUS81, 2 different types of endonucleases with resolvase activities. We propose that various types of resolvase activities are kept in check by the basic N-terminal domain of TRF2 in order to favor an accurate repair of the stalled forks that occur during telomere replication.

Indexed as

Recombination, GeneticDNA-Binding ProteinsEndonucleasesHEK293 CellsHolliday Junction ResolvasesHumansPlasmidsRecombinasesTelomereTelomere HomeostasisTelomeric Repeat Binding Protein 2TransfectionTumor Suppressor Protein p53DNA-Binding ProteinsEndonucleasesGEN1 protein, humanHolliday Junction ResolvasesMUS81 protein, humanRecombinasesSLX4 protein, humanTelomeric Repeat Binding Protein 2TERF2 protein, humanTumor Suppressor Protein p53recombinationshelterintelomereTRF2

Identifiers

PMID25483196
PMCPMC4128890
OpenAlexW1981496089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.